Join us to discover how Becton, Dickinson, and Company (BD), a leader in employee benefits innovation, is transforming its approach to substance use management to enhance employee wellbeing.
As employee benefits evolve, healthcare costs are on the rise and organizations are increasingly recognizing the need to integrate substance use disorder (SUD) treatment into their benefits offerings. A recent study from Business Group on Health found that 22% of employers indicated substance use care is a top priority in 2025, up from 14% in 2023.
Partnering with Pelago and Alight, BD will share their journey and success stories, illustrating how a strategic focus on substance use care can address the gaps in traditional behavioral health strategies.
In this webinar, we will discuss:
- Why BD chose to invest in substance use management.
- How incorporating dedicated SUD care can enhance benefits strategies.
- The role employers can take to close gaps in behavioral health.
Webinar speakers:
Kristen Strobel
Senior Director of Global Benefits, BD
Senior Benefits Executive, Subject Matter Expert, and Industry Thought Leader with 24+ years of experience in designing and delivering employee-focused benefit programs. Kristen’s expertise encompasses a broad spectrum of technical aspects within health and welfare plans, retirement schemes, paid time off approaches and HR policies, ensuring an integrated approach to employee well-being. Kristen is committed to innovative strategic approaches to benefit offerings, plan designs and vendor selection processes aligned with market best practice, organizational goals and ID&E initiatives. Kristen is recognized as a pivotal and dependable Total Rewards leader who fosters a culture of collaboration through a relentless pursuit of excellence steering global benefits and well-being strategies towards measurable success.
Yusuf Sherwani
CEO & Co-Founder, Pelago
Yusuf Sherwani, M.D., is CEO and Co-Founder of Pelago, the leading digital clinic partner to U.S. businesses and health plans for substance use management. Together with his colleagues Maroof Ahmed, M.D., and Sarim Siddiqui, M.D., Yusuf developed a vision for the company’s technology-driven, evidence-based substance use disorder treatment platform. Tens of thousands of members enroll in the Pelago program each year to help manage their substance use and improve their lives, and today more than 3.4 million have access to the digital clinic.
A medical doctor by training and a technology enthusiast at heart, Yusuf is seen as an innovator operating at the intersection of healthcare, technology and design. With a medical degree from Imperial College London, Yusuf has co-authored 12 peer-reviewed studies on behavioral health and substance use disorders. He was featured in Forbes’ 30 Under 30 list (2018) as well as Fast Company’s 100 Most Creative People in Business.
Kathleen Agnew
VP of Product, Alight
Kathleen is a Vice President of Product focused on engagement product solutions and partnerships. She is responsible for expanding the Alight Worklife platform ecosystem of partner integrations to boost employee wellbeing and employer business outcomes. Kathleen has been with Alight for over 20 years and has focused on building partnerships, engagement, and health administration solutions. She has served in various roles across product, client delivery and implementations. Kathleen’s background includes establishing wellbeing and voluntary benefit partnerships and integrations, implementing COBRA and enrollment experiences, leading a health product team and implementation services requirements group, managing ongoing client relationships for health administration engagements, and providing domain leadership to client delivery teams on health legislation and service delivery. Kathleen earned a B.B.A. degree in marketing from Stetson University.
